Total Payments
$10,736
2024 Payments
$829.28
Companies
30
Transactions
458
Medicare Patients
7,169
Medicare Billing
$353,087
Payment Breakdown by Category
Food & Beverage$6,145 (57.2%)
Travel$2,482 (23.1%)
Consulting$2,100 (19.6%)
Education$7.90 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,145 | 450 | 57.2% |
| Travel and Lodging | $2,482 | 5 | 23.1% |
| Consulting Fee | $2,100 | 2 | 19.6% |
| Education | $7.90 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $2,493 | 59 | $0 (2024) |
| Preventice Services, LLC | $2,113 | 3 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $790.55 | 73 | $0 (2024) |
| Medtronic Vascular, Inc. | $715.95 | 12 | $0 (2020) |
| PFIZER INC. | $625.97 | 64 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $551.20 | 39 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $496.53 | 35 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $451.60 | 29 | $0 (2024) |
| Abbott Laboratories | $451.10 | 29 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $418.86 | 27 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $829.28 | 38 | Medtronic, Inc. ($241.16) |
| 2023 | $1,014 | 74 | Boston Scientific Corporation ($187.79) |
| 2022 | $748.56 | 56 | Merck Sharp & Dohme LLC ($145.59) |
| 2021 | $837.97 | 74 | Janssen Pharmaceuticals, Inc ($151.31) |
| 2020 | $444.81 | 34 | Janssen Pharmaceuticals, Inc ($139.20) |
| 2019 | $818.57 | 76 | Janssen Pharmaceuticals, Inc ($160.34) |
| 2018 | $4,171 | 49 | BOSTON SCIENTIFIC CORPORATION ($1,997) |
| 2017 | $1,871 | 57 | Preventice Services, LLC ($1,050) |
All Payment Transactions
458 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $28.32 | General |
| Category: General - Therapies_CRM | ||||||
| 11/21/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/06/2024 | Medtronic, Inc. | ATTAIN COMMAND + SUREVALVE (Device) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Leads | ||||||
| 11/01/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $32.72 | General |
| Category: Cardiovascular Device | ||||||
| 10/29/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/19/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/17/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $21.18 | General |
| Category: Cardiovascular | ||||||
| 09/03/2024 | Volta Medical Inc | VX1 (Device) | Food and Beverage | Cash or cash equivalent | $21.18 | General |
| Category: Cardiovascular | ||||||
| 07/31/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $11.25 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/30/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/25/2024 | Medtronic, Inc. | PULSESELECT (Device) | Food and Beverage | In-kind items and services | $166.60 | General |
| Category: Ablation | ||||||
| 07/25/2024 | Medtronic, Inc. | PULSESELECT (Device) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Ablation | ||||||
| 07/23/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.39 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/23/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/18/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/15/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.28 | General |
| Category: Cardiovascular | ||||||
| 07/08/2024 | Medtronic, Inc. | PULSESELECT (Device) | Food and Beverage | In-kind items and services | $6.64 | General |
| Category: Ablation | ||||||
| 07/03/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.39 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/29/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $5.07 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/11/2024 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: Pacemakers | ||||||
| 05/14/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/17/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.98 | General |
| Category: Cardiovascular | ||||||
| 04/10/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $7.28 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 04/04/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $25.70 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,783 | 2,801 | $261,217 | $88,552 |
| 2022 | 20 | 1,881 | 3,061 | $211,616 | $86,268 |
| 2021 | 22 | 1,808 | 3,051 | $226,451 | $100,099 |
| 2020 | 21 | 1,697 | 2,800 | $194,840 | $78,168 |
Total Patients
7,169
Total Services
11,713
Medicare Billing
$353,087
Procedure Codes
86
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 180 | 228 | $33,692 | $15,724 | 46.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 144 | 188 | $19,233 | $8,642 | 44.9% |
| 93656 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | Facility | 2023 | 11 | 11 | $18,920 | $8,142 | 43.0% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Facility | 2023 | 168 | 361 | $18,255 | $6,899 | 37.8% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 16 | 16 | $13,088 | $6,103 | 46.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 626 | 922 | $22,213 | $5,539 | 24.9% |
| 93280 | Programming of dual lead pacemaker system | Facility | 2023 | 112 | 181 | $32,665 | $4,475 | 13.7% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 38 | 51 | $17,932 | $3,904 | 21.8% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Facility | 2023 | 88 | 173 | $16,687 | $3,892 | 23.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 41 | 41 | $9,076 | $3,670 | 40.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 32 | 33 | $7,026 | $3,226 | 45.9% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Facility | 2023 | 48 | 180 | $7,020 | $2,909 | 41.4% |
| 93283 | Programming of dual lead implantable defibrillator system | Facility | 2023 | 40 | 74 | $6,779 | $2,835 | 41.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 18 | 19 | $5,776 | $2,397 | 41.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 24 | 39 | $4,420 | $2,306 | 52.2% |
| 93284 | Programming of multiple lead implantable defibrillator system | Facility | 2023 | 32 | 48 | $7,775 | $2,005 | 25.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 21 | $3,255 | $1,924 | 59.1% |
| 93290 | Evaluation of implantable heart and blood vessel monitoring system | Facility | 2023 | 68 | 68 | $4,128 | $1,121 | 27.1% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Facility | 2023 | 13 | 56 | $2,185 | $1,046 | 47.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 16 | 16 | $2,633 | $913.92 | 34.7% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Facility | 2023 | 28 | 29 | $1,537 | $535.76 | 34.9% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Facility | 2023 | 18 | 34 | $5,960 | $228.36 | 3.8% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 11 | 12 | $962.00 | $113.03 | 11.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 123 | 148 | $14,800 | $10,222 | 69.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 160 | 229 | $15,057 | $9,940 | 66.0% |
About Dr. Robert Goldstein, M.D
Dr. Robert Goldstein, M.D is a Cardiovascular Disease healthcare provider based in Cleveland, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1255350070.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Goldstein, M.D has received a total of $10,736 in payments from pharmaceutical and medical device companies, with $829.28 received in 2024. These payments were reported across 458 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($6,145).
As a Medicare-enrolled provider, Goldstein has provided services to 7,169 Medicare beneficiaries, totaling 11,713 services with total Medicare billing of $353,087. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Clinical Cardiac Electrophysiology
- Location Cleveland, OH
- Active Since 07/19/2006
- Last Updated 03/03/2021
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1255350070
Products in Payments
- WATCHMAN (Device) $1,994
- XARELTO (Drug) $790.55
- ELIQUIS (Drug) $758.43
- Micra (Device) $630.67
- ENTRESTO (Drug) $535.14
- LifeVest (Device) $496.53
- MULTAQ (Drug) $438.47
- VERQUVO (Drug) $377.01
- VYNDAQEL (Drug) $197.15
- PULSESELECT (Device) $189.23
- PRADAXA (Drug) $173.75
- CardioMEMS HF System (Device) $134.23
- Cardiac Monitoring Suite (Device) $88.54
- Cardiva VASCADE MVP VVCS 6-12F (Device) $77.56
- CHANTIX (Drug) $74.27
- Amplia MRI (Device) $72.29
- Assurity Pacemaker (Device) $68.15
- Optimizer (Device) $67.35
- ANDEXXA (Biological) $62.62
- ENSITE PRECISION (Device) $56.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Cleveland
Guilherme Attizzani
Cardiovascular Disease — Payments: $1.5M
Cardiovascular Disease $1.5M
Abraham Lincoff, Md, MD
Cardiovascular Disease — Payments: $526,643
Cardiovascular Disease $526,643
Walid Saliba, Md, MD
Cardiovascular Disease — Payments: $388,217
Cardiovascular Disease $388,217
Oussama Wazni, Md, MD
Cardiovascular Disease — Payments: $348,033
Cardiovascular Disease $348,033
Dr. Ian Neeland, Md, MD
Cardiovascular Disease — Payments: $340,386
Cardiovascular Disease $340,386
Steven Nissen, Md, MD
Cardiovascular Disease — Payments: $330,365
Cardiovascular Disease $330,365